12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga·02/25/2026 12:05:39
Listen to the news
Gainers
- Quince Therapeutics (NASDAQ:QNCX) stock rose 25.6% to $0.17 during Wednesday's pre-market session. The company's market cap stands at $7.7 million.
- LifeStance Health Gr (NASDAQ:LFST) shares moved upwards by 13.86% to $8.13. The market value of their outstanding shares is at $2.7 billion. As per the news, the Q4 earnings report came out today.
- Kairos Pharma (AMEX:KAPA) stock rose 11.74% to $0.64. The company's market cap stands at $11.9 million.
- Supernus Pharmaceuticals (NASDAQ:SUPN) stock rose 9.94% to $58.6. The company's market cap stands at $2.9 billion. The company's, Q4 earnings came out yesterday.
- Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 9.8% to $0.28. The market value of their outstanding shares is at $9.1 million.
- MediciNova (NASDAQ:MNOV) shares rose 9.62% to $1.48. The company's market cap stands at $66.3 million.
Losers
- Edesa Biotech (NASDAQ:EDSA) stock fell 10.6% to $1.35 during Wednesday's pre-market session. The company's market cap stands at $12.6 million.
- Fortrea Holdings (NASDAQ:FTRE) stock declined by 9.89% to $9.3. The company's market cap stands at $953.5 million.
- Lumexa Imaging Holdings (NASDAQ:LMRI) shares fell 9.66% to $13.0. The market value of their outstanding shares is at $1.3 billion.
- BioRestorative Therapies (NASDAQ:BRTX) shares fell 9.39% to $0.24. The company's market cap stands at $6.2 million.
- Inogen (NASDAQ:INGN) shares decreased by 9.25% to $5.3. The company's market cap stands at $158.5 million. As per the news, the Q4 earnings report came out yesterday.
- Lunai Bioworks (NASDAQ:LNAI) shares declined by 8.07% to $0.4. The market value of their outstanding shares is at $10.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.